RhumbLine Advisers’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Buy
21,134
+2,400
+13% +$53.9K ﹤0.01% 2796
2026
Q1
$423K Buy
18,734
+1,394
+8% +$32K ﹤0.01% 2712
2025
Q4
$413K Buy
17,340
+3,251
+23% +$80.9K ﹤0.01% 2788
2025
Q3
$371K Sell
14,089
-2,144
-13% -$55.1K ﹤0.01% 2877
2025
Q2
$464K Sell
16,233
-120
-0.7% -$3.22K ﹤0.01% 2730
2025
Q1
$407K Buy
16,353
+301
+2% +$7.17K ﹤0.01% 2702
2024
Q4
$363K Sell
16,052
-2,275
-12% -$49.4K ﹤0.01% 2874
2024
Q3
$390K Buy
18,327
+260
+1% +$5.12K ﹤0.01% 2876
2024
Q2
$345K Buy
18,067
+1,128
+7% +$23K ﹤0.01% 2920
2024
Q1
$327K Buy
16,939
+1,763
+12% +$34.9K ﹤0.01% 2939
2023
Q4
$316K Buy
15,176
+200
+1% +$3.84K ﹤0.01% 2938
2023
Q3
$323K Buy
14,976
+335
+2% +$8.13K ﹤0.01% 2891
2023
Q2
$350K Buy
+14,641
New +$336K ﹤0.01% 2911
2018
Q4
– Sell
-5,111
Closed -$263K – 2977
2018
Q3
$263K Buy
+5,111
New +$256K ﹤0.01% 2584
2016
Q3
– Sell
-5,466
Closed -$238K – 2899
2016
Q2
$238K Hold
5,466
– – ﹤0.01% 2652
2016
Q1
$241K Hold
5,466
– – ﹤0.01% 2642
2015
Q4
$229K Buy
5,466
+327
+6% +$13.8K ﹤0.01% 2723
2015
Q3
$200K Buy
5,139
+136
+3% +$5.54K ﹤0.01% 2782
2015
Q2
$208K Sell
5,003
-2,700
-35% -$115K ﹤0.01% 2870
2015
Q1
$319K Buy
7,703
+963
+14% +$37.2K ﹤0.01% 2575
2014
Q4
$250K Hold
6,740
– – ﹤0.01% 2679
2014
Q3
$234K Hold
6,740
– – ﹤0.01% 2665
2014
Q2
$226K Hold
6,740
– – ﹤0.01% 2763
2014
Q1
$235K Hold
6,740
– – ﹤0.01% 2679
2013
Q4
$240K Buy
+6,740
New +$226K ﹤0.01% 2722

Other funds holding FMS

RhumbLine Advisers's FMS Position: Q2 2026 in Review

RhumbLine Advisers increased its Fresenius Medical Care (FMS) stake by 13% in Q2 2026, buying an estimated $53.9K and bringing the position to 21,134 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #2796.

RhumbLine Advisers first reported a position in FMS in Q4 2013 and has held it in 25 quarters since. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • RhumbLine Advisers held 21,134 shares of Fresenius Medical Care worth $478K as of Q2 2026.
  • RhumbLine Advisers bought 2,400 Fresenius Medical Care shares in Q2 2026, an estimated $53.9K.
  • Fresenius Medical Care made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2796 holding.
  • RhumbLine Advisers first reported a position in Fresenius Medical Care in Q4 2013 and has held it in 25 quarters since.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.